Federal Funding Update: Fiscal Year 2019

December 10, 2018

UPDATE:  On December 22, 2018 at 12:01 a.m. the United States government entered into a partial shutdown after Congress and the Administration failed to come to an agreement on a Continuing Resolution (CR). Learn more.


On Friday, December 7, President Trump signed into law a two-week Continuing Resolution (CR) to prevent a partial government shutdown.

While Congress was able to pass some of its Fiscal Year (FY) 2019 appropriations bills before the end of the 2018 fiscal year, it has not yet come to agreement on seven remaining appropriations bills, which fund a variety of federal departments and agencies, including the Food and Drug Administration (FDA). The CR will provide flat funding for those agencies until December 21, 2018, when Congress will need to take further action to fund them.

ASCO has urged Congress to provide $3.32 billion in funding for the Food and Drug Administration (FDA) in FY 2019, as well as support for the Administration’s request of $20 million for FDA’s Oncology Center of Excellence (OCE).

Congress has already provided funding through the end of FY 2019 for the Department of Health and Human Services (HHS), which includes funding for the National Institutes of Health (NIH) and National Cancer Institute (NCI). The funding bill included a $2 billion increase for the NIH, a $79 million increase for the NCI, and $400 million for the Beau Biden Cancer Moonshot for FY 2019.

Read ASCO in Action for the latest updates on federal funding and other policy issues.